47 related articles for article (PubMed ID: 9308224)
1. Reflections on 30 years of publishing osteoarthritis research: Where we've been and where we're going.
Yau MS; Filbay SR; Block JA; Lohmander LS
Osteoarthritis Cartilage; 2024 Apr; 32(4):349-351. PubMed ID: 38401669
[No Abstract] [Full Text] [Related]
2. Insights From the Oncology Care First Proposal-Where We've Been and Where We're Going in Value-Based Care.
Young G; Schleicher SM; Dickson NR; Lyss AJ
JCO Oncol Pract; 2020 Apr; 16(4):151-153. PubMed ID: 32097082
[No Abstract] [Full Text] [Related]
3. Effect of a c-MYC Gene Polymorphism (g.3350G>C) on Meat Quality Traits in Berkshire.
Oh JD; Kim ES; Lee HK; Song KD
Asian-Australas J Anim Sci; 2015 Nov; 28(11):1545-50. PubMed ID: 26580277
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation and expression profiling of the ENO1 gene in the ovarian follicle of the Sichuan white goose.
Kang B; Jiang DM; Bai L; He H; Ma R
Mol Biol Rep; 2014; 41(4):1927-35. PubMed ID: 24413993
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cell-based gene therapy for brain tumors.
Kim SU
Stem Cell Rev Rep; 2011 Mar; 7(1):130-40. PubMed ID: 20521177
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces differential translation of enolase/MBP-1.
Sedoris KC; Thomas SD; Miller DM
BMC Cancer; 2010 Apr; 10():157. PubMed ID: 20412594
[TBL] [Abstract][Full Text] [Related]
7. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.
Louis SF; Vermolen BJ; Garini Y; Young IT; Guffei A; Lichtensztejn Z; Kuttler F; Chuang TC; Moshir S; Mougey V; Chuang AY; Kerr PD; Fest T; Boukamp P; Mai S
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9613-8. PubMed ID: 15983382
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional consequences of topoisomerase inhibition.
Collins I; Weber A; Levens D
Mol Cell Biol; 2001 Dec; 21(24):8437-51. PubMed ID: 11713279
[TBL] [Abstract][Full Text] [Related]
9. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.
He L; Liu J; Collins I; Sanford S; O'Connell B; Benham CJ; Levens D
EMBO J; 2000 Mar; 19(5):1034-44. PubMed ID: 10698944
[TBL] [Abstract][Full Text] [Related]
10. Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells.
Sun Y; Clark EA
J Exp Med; 1999 May; 189(9):1391-8. PubMed ID: 10224279
[TBL] [Abstract][Full Text] [Related]
11. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
Ren B; Chee KJ; Kim TH; Maniatis T
Genes Dev; 1999 Jan; 13(1):125-37. PubMed ID: 9887105
[TBL] [Abstract][Full Text] [Related]
12. Myc goes global: new tricks for an old oncogene.
Knoepfler PS
Cancer Res; 2007 Jun; 67(11):5061-3. PubMed ID: 17545579
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
14. [In vivo regulation of c-myc proto-oncogene: contribution of transgenic mice].
Morello D
Pathol Biol (Paris); 1993 May; 41(5):453-5. PubMed ID: 8414677
[No Abstract] [Full Text] [Related]
15. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
[TBL] [Abstract][Full Text] [Related]
16. The c-myc story: where we've been, where we seem to be going.
Potter M; Marcu KB
Curr Top Microbiol Immunol; 1997; 224():1-17. PubMed ID: 9308224
[No Abstract] [Full Text] [Related]
17. [File no.47: CMYC].
Soussi T
Bull Cancer; 2001 Nov; 88(11):1053-4. PubMed ID: 11741797
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
